Health insurance may appear to be a simple financial business. An insurer receives premiums from customers, pays eligible medical claims, covers its own costs, and seeks to earn a profit. The actual business model is more complex.
An investor who studies a health insurer may need to assess several factors at the same time. These include premium growth, medical claims, operating costs, customer retention, medical cost inflation, regulation, capital needs and investment income.
A rise in premiums does not by itself prove that an insurer has a strong business. A company may report fast premium growth while also face high claim costs. In such a case, revenue may rise without a similar rise in profit.
The main point for an investor is simple: the quality of premium growth matters. A useful analysis should look at how much of each premium remains after claims and other costs, how much capital the insurer needs, and whether the business can earn a reasonable return on that capital.
How the Health Insurance Model Works
A health insurer receives premiums from policyholders. It then uses part of that money to pay valid medical claims and part to cover its operating and distribution costs.
A simplified view of the business is shown below.
| Measure | Simple explanation |
|---|---|
| Premiums | Money received from policyholders |
| Medical claims | Amount paid or reserved for covered medical costs |
| Operating expenses | Costs such as administration and claims support |
| Distribution costs | Costs linked to agents, brokers and other sales channels |
| Underwriting profit | Premiums left after claims and relevant expenses |
| Investment income | Income earned on funds held before they are required for claims |
The insurer may therefore have two broad sources of economic value. The first is its insurance business itself. The second is the income it may earn from the funds it holds before those funds are required for claims and other obligations.
For this reason, an investor should not assess an insurer only through its revenue or premium growth. The quality of underwriting and the use of capital can be equally important.
Medical Loss Ratio
The Medical Loss Ratio, often called MLR, is one of the basic measures used to assess health insurance economics.
The formula is simple:
MLR = Medical claims ÷ Earned premiums
Suppose an insurer receives $100 in earned premiums and has $82 of medical claims. Its MLR would be 82%. This leaves $18 before other expenses.
A lower MLR can support stronger insurer economics, but the figure should not be viewed on its own. A very low ratio may not always mean that a business has superior economics. An investor may also need to assess product terms, claim reserves, customer mix and applicable rules.
In the United States, the Affordable Care Act generally requires insurers to spend at least 80% of premiums on clinical care and quality improvement in the individual and small-group markets. The requirement is generally 85% for large-group markets.
The direction of the ratio may be as important as its current level. If an insurer has an MLR of 76% but the ratio moves toward 85%, the change may deserve close review. If the ratio moves from 85% to 78%, the change may indicate better underwriting conditions, although the reason should still be examined.
Medical Cost Inflation
Medical cost inflation is a major factor in health insurance economics.
An insurer may set premiums based on an estimate of future claims. If medical costs rise faster than expected, the original premium may prove less adequate than expected.
Consider a simple example. An insurer expects premium growth of 10% and medical cost growth of 7%. If medical costs instead rise by 12% or 15%, the gap between premium growth and claim-cost growth can become much smaller.
The company may later adjust prices, but the timing and extent of such changes can vary by product and market.
Recent U.S. industry data illustrates this issue. The National Association of Insurance Commissioners reported that hospital and medical expenses rose 16.2% year over year in the first half of 2025. The same report placed the industry’s loss ratio at about 88.6%.
These figures should not be treated as a forecast for every insurer. Individual companies may have different customer groups, products, geographic exposure and contract structures. They do, however, show why medical cost trends can have a material effect on insurance margins.
Growth Does Not Always Mean Better Economics
Premium growth can look attractive in a financial report. It is still important to ask what the insurer earns from that growth.
Consider the following simplified comparison.
| Measure | Insurer A | Insurer B |
|---|---|---|
| Premium growth | 25% | 12% |
| MLR | 82% | 76% |
| Expense ratio | 15% | 13% |
| Underwriting margin | 3% | 11% |
Insurer A has much faster premium growth. Insurer B, however, has a lower MLR, a lower expense ratio and a higher underwriting margin.
This does not mean Insurer B is automatically the better investment. An investor would still need to review valuation, capital needs, growth prospects, regulation, balance-sheet strength and other factors.
The example shows a broader point: premium growth alone may provide an incomplete picture of business quality.
A useful question is whether new customers and new premiums can produce an adequate economic return after claims, expenses and capital needs.
Distribution Costs
The way an insurer sells its products can have a major effect on its economics.
Health insurance may reach customers through agents, brokers, banks, direct sales, digital platforms, employers or other channels. Each channel can have a different cost structure.
A company with high acquisition costs may need a customer to remain with it for several years before the initial cost is recovered.
Customer retention can therefore have a direct effect on economics. If customers renew their policies for many years, the insurer may have more time to recover acquisition costs and earn a return from the relationship.
An investor may therefore study premium growth together with renewal rates, persistency, acquisition costs and customer lifetime value.
Customer Retention
Health insurance has an important feature that can differ from many ordinary consumer products. A policyholder may remain with the same insurer for several years.
This can create value if the insurer has suitable pricing, good service and reasonable customer retention.
A company that pays a high cost to acquire a customer but retains that customer for a long period may have a different economic profile from a company that acquires customers cheaply but loses many of them at renewal.
The quality of the customer base also matters. Different groups may have different claim patterns and different levels of profitability.
For that reason, an investor may find it useful to assess customer cohorts rather than rely only on total policy numbers.
Claims Management
Claims are at the centre of health insurance economics.
Two insurers may have similar premium revenue but different profit levels because their claim costs differ. Differences may arise from customer mix, medical conditions, claim severity, fraud controls, hospital contracts and internal processes.
Claims management may include fraud detection, medical review, pre-authorisation, provider negotiations and claim assessment.
Technology may also affect these processes. Better systems can help insurers identify unusual claims, improve administrative processes and support faster decisions. However, technology alone does not guarantee better financial results.
An investor should therefore look for evidence of durable improvement rather than assume that a technology investment will automatically produce higher margins.
Hospitals and Healthcare Providers
Health insurers operate within a wider healthcare system. Hospitals, doctors, pharmaceutical companies, patients, insurers and other parties all affect the final cost of care.
Hospital prices can have a direct effect on claims. If medical providers gain greater pricing power, an insurer may face higher claim costs. The insurer may then need to seek higher premiums or accept lower margins, subject to market conditions and applicable rules.
The strength of an insurer’s provider network can therefore matter.
Factors such as hospital concentration, negotiated rates, cashless access, average claim size and the type of procedures covered may help an investor understand the underlying risk.
In some markets, insurers also have links with other healthcare businesses. Such structures can alter the economics of the overall group and may require separate analysis.
Regulation
Health insurance is a highly regulated sector. Rules may affect product design, pricing, commissions, claims, capital, solvency and customer protection.
Regulatory change can therefore affect earnings even when an insurer’s core operations remain stable.
For example, changes to distribution commissions or expense rules can alter the amount of money that reaches insurers, agents, brokers or other intermediaries.
An investor should therefore avoid treating regulation as a minor issue. It can form a material part of the investment case.
At the same time, regulatory outcomes can be uncertain. An investor should distinguish between confirmed rules, proposed changes and market expectations.
Capital Efficiency
Insurance is also a capital-intensive financial business.
An insurer may require capital to support its liabilities, protect policyholders and satisfy regulatory requirements. Fast growth can therefore create a need for additional capital.
This makes capital efficiency important.
| Metric | What it may show |
|---|---|
| ROE | Return earned on shareholders’ equity |
| Solvency ratio | Financial strength relative to regulatory requirements |
| Capital adequacy | Ability to support insurance obligations |
| Underwriting return | Economic result from insurance operations |
| Premium-to-capital ratio | Relationship between premium volume and available capital |
| Dividend capacity | Potential ability to return excess capital |
A company that grows rapidly but needs large amounts of new capital may have different economics from a slower-growing company that generates excess capital.
The appropriate conclusion will depend on the insurer’s market, regulation, product mix and financial position.
The Indian Health Insurance Market
India presents a separate set of factors for investors to assess.
Health insurance penetration has room for further expansion, which may provide a long-term opportunity for insurers. However, market growth does not automatically mean high profitability.
The distinction between retail health insurance and group health insurance is especially important.
Milliman’s India survey reported a 96% loss ratio for group health insurance in the referenced FY2022–23 data. This figure illustrates why strong premium growth in group insurance does not necessarily produce attractive underwriting returns.
The figure should be read in its stated context. It does not represent every insurer or every future period.
Distribution is another important area. Changes in commission structures and expense rules can affect the economics of insurers and intermediaries in different ways.
Medical cost inflation also deserves close attention. If hospital and treatment costs rise faster than insurers can adjust prices, margins may face pressure.
A Simple Investor Framework
An investor who wants to study a health insurer can reduce the analysis to a basic chain.
| Area | Core question |
|---|---|
| Customers | Is the customer base expanding at a healthy rate? |
| Premiums | Is premium growth profitable? |
| Claims | Are claim costs under control? |
| Expenses | Is the cost base efficient? |
| Retention | Do customers renew their policies? |
| Capital | How much capital does growth require? |
| Regulation | Could rule changes affect the business? |
| Returns | Does the company earn an attractive return on capital? |
This framework does not provide an investment conclusion by itself. It is a starting point for further work.
The quality of the analysis may improve when these measures are reviewed across several years rather than for one financial period. One year can contain unusual claims, changes in medical costs, regulatory effects or other temporary factors.
What Investors Should Watch
A practical health insurance analysis can focus on ten core measures: premium growth, MLR or loss ratio, expense ratio, combined ratio, renewal or persistency, claim severity, acquisition cost, ROE, solvency and investment income.
These measures should be viewed together.
For example, high premium growth with a rising loss ratio may deserve caution. A lower loss ratio with weak customer retention may require further review. Strong ROE with high leverage or weak capital support may also need closer examination.
The purpose is not to find one perfect number. The purpose is to understand how the business works and whether its results appear durable.
The Main Investor Risk
One of the simplest mistakes is to assume that a 20% rise in customers should lead to a similar rise in profit.
That conclusion may be too simple.
The economic path is closer to:
Customers → Premiums → Claims → Expenses → Underwriting result → Capital needs → Return on capital
There is also a separate investment-income path:
Premiums and reserves → Funds held by insurer → Investment income → Total financial result
Both paths can affect shareholder returns.
Conclusion
Health insurance can offer a large market opportunity, but the analysis requires more than a review of premium growth.
The central issue is the relationship between premiums, claims, expenses and capital. Medical inflation can affect claim costs. Distribution can affect customer acquisition costs. Customer retention can affect the lifetime value of a policy. Regulation can alter the economics of products and sales channels. Capital requirements can affect the ability of an insurer to convert growth into shareholder returns.
For investors, the most useful approach may be to place greater weight on sustainable underwriting quality and capital efficiency rather than headline premium growth alone.
No single ratio can establish whether a health insurer is a suitable investment. A proper assessment should also consider the company’s valuation, financial statements, disclosures, regulatory position, market conditions, competitors and the risks specific to its business.
The figures and examples above are intended for general analytical purposes only. They should not be treated as a recommendation to buy, sell or hold any security, nor as a prediction of future financial performance.
ALSO READ: How to Check an IPO Before You Apply With Confidence
